scholarly journals OP30.04: Fusion imaging (FI) in brain structure measurements on a fetus phantom when combining real-time ultrasound (US) with magnetic resonance imaging (MRI)

2017 ◽  
Vol 50 ◽  
pp. 146-147
Author(s):  
A. Arechvo ◽  
L. Jokubkiene ◽  
L. Thurn ◽  
G. Lingman
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Real Time ◽  
Brain Structure ◽  
Fusion Imaging ◽  
Resonance Imaging ◽  
Magnetic Resonance Imaging Mri

SU-GG-J-164: Real-Time Magnetic Resonance Imaging (MRI) Guidance and Thermal Modeling to Focus Hyperthermia Delivery

2008 ◽  
Vol 35 (6Part8) ◽  
pp. 2717-2717
Author(s):  
V Stakhursky ◽  
K Cheng ◽  
J MacFall ◽  
P Maccarini ◽  
P Stauffer ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Real Time ◽  
Thermal Modeling ◽  
Resonance Imaging ◽  
Mri Guidance ◽  
Magnetic Resonance Imaging Mri

scholarly journals Biomarkers for autism spectrum disorder: opportunities for magnetoencephalography (MEG)

2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Timothy P. L. Roberts ◽  
Emily S. Kuschner ◽  
J. Christopher Edgar
Keyword(s):  
Magnetic Resonance Imaging ◽  
Autism Spectrum Disorder ◽  
Magnetic Resonance ◽  
Brain Structure ◽  
Brain Dysfunction ◽  
Autism Spectrum ◽  
Intellectual And Developmental Disabilities ◽  
Resonance Imaging ◽  
Children With Asd ◽  
Magnetic Resonance Imaging Mri

AbstractThis paper reviews a candidate biomarker for ASD, the M50 auditory evoked response component, detected by magnetoencephalography (MEG) and presents a position on the roles and opportunities for such a biomarker, as well as converging evidence from allied imaging techniques (magnetic resonance imaging, MRI and spectroscopy, MRS). Data is presented on prolonged M50 latencies in ASD as well as extension to include children with ASD with significant language and cognitive impairments in whom M50 latency delays are exacerbated. Modeling of the M50 latency by consideration of the properties of auditory pathway white matter is shown to be successful in typical development but challenged by heterogeneity in ASD; this, however, is capitalized upon to identify a distinct subpopulation of children with ASD whose M50 latencies lie well outside the range of values predictable from the typically developing model. Interestingly, this subpopulation is characterized by low levels of the inhibitory neurotransmitter GABA. Following from this, we discuss a potential use of the M50 latency in indicating “target engagement” acutely with administration of a GABA-B agonist, potentially distinguishing “responders” from “non-responders” with the implication of optimizing inclusion for clinical trials of such agents. Implications for future application, including potential evaluation of infants with genetic risk factors, are discussed. As such, the broad scope of potential of a representative candidate biological marker, the M50 latency, is introduced along with potential future applications.This paper outlines a strategy for understanding brain dysfunction in individuals with intellectual and developmental disabilities (IDD). It is proposed that a multimodal approach (collection of brain structure, chemistry, and neuronal functional data) will identify IDD subpopulations who share a common disease pathway, and thus identify individuals with IDD who might ultimately benefit from specific treatments. After briefly demonstrating the need and potential for scope, examples from studies examining brain function and structure in children with autism spectrum disorder (ASD) illustrate how measures of brain neuronal function (from magnetoencephalography, MEG), brain structure (from magnetic resonance imaging, MRI, especially diffusion MRI), and brain chemistry (MR spectroscopy) can help us better understand the heterogeneity in ASD and form the basis of multivariate biological markers (biomarkers) useable to define clinical subpopulations. Similar approaches can be applied to understand brain dysfunction in neurodevelopmental disorders (NDD) in general. In large part, this paper represents our endeavors as part of the CHOP/Penn NICHD-funded intellectual and developmental disabilities research center (IDDRC) over the past decade.

Sign in / Sign up

Export Citation Format

Share Document